Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report: Chromophobe renal cell carcinoma (ChRCC) is a rare pathological type of renal cell carcinoma (RCC). Related systematic…… #oncology https://t.co
18,077 followers
12,152 followers
RT @FrontOncology: New research: Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case re…
98 followers
New research: Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report: Chromophobe renal cell carcinoma (ChRCC) is a rare pathological type of renal cell carcinoma (RCC). Related systematic… https://t.
6,546 followers
New research: Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report: Chromophobe renal cell carcinoma (ChRCC) is a rare pathological type of renal cell carcinoma (RCC). Related systematic… https://t.